+82-43-234-5101 Copyright 2022 BMI KOREA All RIGHTS RESERVED.
(2015) 308:G90423
US 7713947 & US 8377903 - Cladribine Regimen for Treating Multiple Sclerosis, relate to dosage regimen (947 claim 36: oral administration of cladribine in a total dosage of about 1.7 to 3.5 mg/kg over a short induction period, followed by extended cladribine-free intervals and subsequent maintenance courses)
No significant changes in GABA-T, GAD and DAO activities, Put and Spm levels for the two different temperatures compared to controls, while application of exogenous GABA
Choose a syringe if you inject infrequently (weekly or less), if you use many different peptides and switching cartridges would be impractical, if cost is the primary concern and you have steady hands with good vision, or if your doses are large enough that syringe accuracy is adequate
Very few include a direct discussion of body composition monitoring, protein targets, or resistance training protocols